Brief: Tonix Pharmaceuticals Expects About $50 Mln Non-Cash Impairment For Quarter Ended June 30, 2024
24/07/2024 23:04
July 24 (Reuters) - Tonix Pharmaceuticals Holding Corp
TNXP.O :
* TONIX PHARMACEUTICALS HOLDING: EXPECTS FINANCIAL
STATEMENTS FOR
QUARTER ENDED JUNE 30, 2024 WILL REFLECT A NON-CASH IMPAIRMENT
OF ABOUT $50 MILLION
Source text for Eikon: ID:n0001999371-24-009003
Further company coverage: TNXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tonix Pharmaceuticals Holding
See all newsBrief: Tonix Pharmaceuticals Says Dr. Reddy's Files ANDA With Paragraph IV Patent Certification For Generic Tonmya
Brief: Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement For Tonmya®
Tonix Pharmaceuticals Holding Corp. reports results for the quarter ended June 30 - Earnings Summary
Tonix Q2 revenue rises sharply on TONMYA launch
Tonix Pharmaceuticals Holding Corp. expected to post a loss of $2.70 a share - Earnings Preview